Rice Hall James & Associates’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$13.6M Sell
108,382
-1,291
-1% -$162K 0.73% 40
2025
Q1
$12.1M Sell
109,673
-959
-0.9% -$106K 0.71% 42
2024
Q4
$15.1M Sell
110,632
-6,785
-6% -$926K 0.83% 34
2024
Q3
$13.5M Sell
117,417
-688
-0.6% -$79.3K 0.73% 42
2024
Q2
$16.3M Sell
118,105
-8,316
-7% -$1.14M 0.98% 25
2024
Q1
$17.4M Sell
126,421
-5,200
-4% -$717K 1% 25
2023
Q4
$17.3M Sell
131,621
-592
-0.4% -$78K 1% 26
2023
Q3
$14.9M Sell
132,213
-2,857
-2% -$321K 0.94% 31
2023
Q2
$12.7M Sell
135,070
-2,167
-2% -$204K 0.72% 43
2023
Q1
$13.9M Sell
137,237
-12,130
-8% -$1.23M 0.79% 36
2022
Q4
$17.8M Sell
149,367
-3,552
-2% -$424K 1.02% 26
2022
Q3
$16.2M Sell
152,919
-49,627
-25% -$5.27M 0.94% 29
2022
Q2
$19.7M Sell
202,546
-4,209
-2% -$410K 0.95% 31
2022
Q1
$19.4M Buy
206,755
+136,782
+195% +$12.8M 0.77% 39
2021
Q4
$5.96M Sell
69,973
-8,052
-10% -$686K 0.21% 93
2021
Q3
$7.48M Sell
78,025
-5,231
-6% -$502K 0.28% 77
2021
Q2
$8.1M Sell
83,256
-14
-0% -$1.36K 0.29% 74
2021
Q1
$8.1M Sell
83,270
-3,848
-4% -$374K 0.26% 78
2020
Q4
$8.35M Buy
87,118
+12,938
+17% +$1.24M 0.29% 73
2020
Q3
$7.13M Buy
74,180
+9,140
+14% +$879K 0.29% 75
2020
Q2
$7.94M Sell
65,040
-993
-2% -$121K 0.34% 82
2020
Q1
$5.72M Sell
66,033
-824
-1% -$71.3K 0.32% 92
2019
Q4
$7.19M Buy
66,857
+5,362
+9% +$576K 0.24% 115
2019
Q3
$5.54M Sell
61,495
-654
-1% -$58.9K 0.2% 116
2019
Q2
$5.25M Sell
62,149
-11,575
-16% -$977K 0.17% 126
2019
Q1
$6.5M Buy
73,724
+29,983
+69% +$2.64M 0.21% 121
2018
Q4
$3.12M Buy
+43,741
New +$3.12M 0.11% 134